Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia

Share

  • 1

    ISoP LATAM organized symposia to enhance pharmacovigilance by uniting regulators, academia, and industry across Latin America.

  • 2

    Key priorities identified include regulatory convergence, real-world evidence integration, and prevention of medication errors.

  • 3

    Expanding pharmacovigilance education and promoting patient engagement are essential for improving drug safety in the region.

  • 4

    The symposia facilitated discussions on common challenges and proposed strategies for strengthening pharmacovigilance capacity.

  • 5

    Regional collaboration is crucial to address the diverse regulatory frameworks and resource limitations in Latin American countries.

Original Source(s)

Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia

  • by Jessica Liliana Vargas-Neri, Angela Caro-Rojas, Gilberto Castañeda-Hernández, Christian Camilo Cuello-Meza, Betty Duarte, Daniela Fontana, Cinthya Galicia-Quintanar, Victoria Hall-Ramírez, Diego Salas, Maribel Salas, Julia Jeanett Segura-Uribe, Mónica Tarapues, Heyde Patricia Zuluaga-Arias, Carlos Aceves-González, Josué Bautista-Arteaga, William Carreño-Quintero, Daniela Daza-Paz, Diana María González-Achury, Rosana Angélica Ramírez-Pedreros, Diego Armando Galvis-Sánchez, Luz Dary Terán-Mercado

  • March 21, 2026

Related Content

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

Please join us to hear Omar F. Abou-Ezzeddine, M.D.C.M., M.S., at the Lawrence Blacher, M.D., Memorial Lecture, where he will provide a 2026 update on amyloid cardiomyopathy, highlighting current diagnostic strategies, emerging therapies, and practical approaches to patient care.

  • by

  • March 20, 2026

  • 1 min
ECPR Shows Promise in Cardiac Arrest

Timing, patient selection, and system factors continue to shape its role

Statins and Survival After 80

Cohort analysis associates primary prevention with lower mortality and coronary morbidity